4/3 MannKind: Afrezza Scripts Remain Underwhelming •Afrezza sales remain well below 300 scripts per week. •MannKind cash continues to dwindle. •Some form of capital raise needs to happen in Q2 https://seekingalpha.com/article/4059918-mannkind-afrezza-scripts-remain-underwhelming?app=1&auth_param=1vat:1ce58tq:a210adf86817aeba85b37d2ab8438d1a&uprof=51